Skip to main content
Equibles
TWST logo

TWST · Twist Bioscience Corp · Webcasts, Transcripts & Audio

Track TWST — free

Use TWST with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TWST.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$159.85 +14.60 (+10.05%) At close · Oct 27 Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$9.84B
Shares
62.71M
Volume · Oct 27 1.76M Avg daily vol (3M) 2.25M

Twist Bioscience Corp Webcasts

Earnings calls, investor updates, investor days and conferences for Twist Bioscience Corp (TWST), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY26 · Q4
2026-11-12
Twist Bioscience Corp (TWST) Q4 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-09-15
Twist Bioscience Corp (TWST) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-08-03
Twist Bioscience Corp (TWST) Q3 2026 Earnings Call Transcript
Confident tone Capacity expansion / supply AI-enabled drug discovery Competitive positioning vs. GenScript and others
Revenue
$118.38M
▲ 23.2% YoY
Diluted EPS
$-0.56
▼ 269.7% YoY
Gross margin
52.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-02
Twist Bioscience Corp (TWST) June 2, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Capital Markets Day
Investor event
2026-05-21
Twist Bioscience Corp (TWST) May 21, 2026 Capital Markets Day Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-05-04
Twist Bioscience Corp (TWST) Q2 2026 Earnings Call Transcript
Confident tone NGS and oncology diagnostics Path to adjusted EBITDA breakeven DNA synthesis and Protein Solutions growth
Revenue
$110.72M
▲ 19.3% YoY
Diluted EPS
$-0.71
Gross margin
51.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-02-17
Twist Bioscience Corp (TWST) February 17, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-02-02
Twist Bioscience Corp (TWST) Q1 2026 Earnings Call Transcript
Confident tone NGS and diagnostic partnerships Gross margin and SAM expansion DNA synthesis platform and NPI engine
Revenue
$103.70M
▲ 16.9% YoY
Diluted EPS
$-0.50
Gross margin
52.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-11-14
Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Transcript
Positive tone NGS and MRD Segment realignment (DNA Synthesis and Protein Solutions) Gross margin improvement
Revenue
$99.01M*
▲ 16.9% YoY
Gross margin
51.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-08-04
Twist Bioscience Corp (TWST) Q3 2025 Earnings Call Transcript
Confident tone Financial Performance and Records NGS / Diagnostics Growth Gross Margin Expansion and Path to Profitability
Revenue
$96.06M
▲ 17.9% YoY
Diluted EPS
$0.33
Gross margin
53.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-05-05
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Transcript
Confident tone Revenue Growth and Records NGS and AgBio Expansion US Academic Market and Policy Environment
Revenue
$92.79M
▲ 23.2% YoY
Diluted EPS
$-0.66
Gross margin
49.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-02-03
Twist Bioscience Corp (TWST) Q1 2025 Earnings Call Transcript
Confident tone NGS and Liquid Biopsy Gross Margin Expansion Revenue Growth and Beat
Revenue
$88.71M
▲ 24.1% YoY
Diluted EPS
$-0.53
Gross margin
48.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-11-18
Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Transcript
Confident tone NGS / MRD growth Biopharma segment traction Gross margin expansion and path to adjusted EBITDA breakeven
Revenue
$84.71M*
▲ 26.5% YoY
Gross margin
45.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-08-02
Twist Bioscience Corp (TWST) Q3 2024 Earnings Call Transcript
Confident tone Revenue Growth and Financial Performance NGS and Clinical Markets SynBio and Express Genes
Revenue
$81.46M
▲ 27.8% YoY
Diluted EPS
$-1.47
Gross margin
43.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-05-02
Twist Bioscience Corp (TWST) Q2 2024 Earnings Call Transcript
Confident tone Express Genes product launch and growth NGS revenue and clinical customers Gross margin expansion toward profitability
Revenue
$75.30M
▲ 25.1% YoY
Diluted EPS
$-0.79
Gross margin
41.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-02-02
Twist Bioscience Corp (TWST) Q1 2024 Earnings Call Transcript
Confident tone NGS market expansion and customer wins Path to profitability and margin expansion Revenue growth and record quarter
Revenue
$71.50M
▲ 31.8% YoY
Diluted EPS
$-0.75
Gross margin
40.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-11-17
Twist Bioscience Corp (TWST) Q4 2023 Earnings Call Transcript
Revenue
$66.95M*
▲ 16.8% YoY
Gross margin
36.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-08-04
Twist Bioscience Corp (TWST) Q3 2023 Earnings Call Transcript
Revenue
$63.74M
▲ 13.6% YoY
Diluted EPS
$-1.01
Gross margin
34.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-05-05
Twist Bioscience Corp (TWST) Q2 2023 Earnings Call Transcript
Revenue
$60.18M
▲ 25% YoY
Diluted EPS
$-1.04
Gross margin
30.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-02-03
Twist Bioscience Corp (TWST) Q1 2023 Earnings Call Transcript
Revenue
$54.24M
▲ 29.1% YoY
Diluted EPS
$-0.74
Gross margin
45.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-11-18
Twist Bioscience Corp (TWST) Q4 2022 Earnings Call Transcript
Revenue
$57.31M*
▲ 51% YoY
Gross margin
44.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-08-05
Twist Bioscience Corp (TWST) Q3 2022 Earnings Call Transcript
Revenue
$56.11M
▲ 60.2% YoY
Diluted EPS
$-1.08
Gross margin
44.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-05-05
Twist Bioscience Corp (TWST) Q2 2022 Earnings Call Transcript
Revenue
$48.13M
▲ 54.2% YoY
Diluted EPS
$-1.13
Gross margin
38.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-02-04
Twist Bioscience Corp (TWST) Q1 2022 Earnings Call Transcript
Revenue
$42.02M
▲ 49.2% YoY
Diluted EPS
$-0.91
Gross margin
35.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-11-22
Twist Bioscience Corp (TWST) Q4 2021 Earnings Call Transcript
Revenue
$37.95M*
▲ 17% YoY
Gross margin
40.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-08-06
Twist Bioscience Corp (TWST) Q3 2021 Earnings Call Transcript
Revenue
$35.02M
▲ 65.1% YoY
Diluted EPS
$-0.82
Gross margin
40.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-05-06
Twist Bioscience Corp (TWST) Q2 2021 Earnings Call Transcript
Revenue
$31.20M
▲ 61.7% YoY
Diluted EPS
$-0.78
Gross margin
39.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-02-04
Twist Bioscience Corp (TWST) Q1 2021 Earnings Call Transcript
Revenue
$28.16M
▲ 64.1% YoY
Gross margin
35.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-11-23
Twist Bioscience Corp (TWST) Q4 2020 Earnings Call Transcript
Revenue
$32.43M*
▲ 106.1% YoY
Gross margin
45.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-08-06
Twist Bioscience Corp (TWST) Q3 2020 Earnings Call Transcript
Revenue
$21.21M
▲ 55.9% YoY
Gross margin
22.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-05-07
Twist Bioscience Corp (TWST) Q2 2020 Earnings Call Transcript
Revenue
$19.30M
▲ 42.3% YoY
Gross margin
29.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-02-06
Twist Bioscience Corp (TWST) Q1 2020 Earnings Call Transcript
Revenue
$17.16M
▲ 49.4% YoY
Gross margin
19.6%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–32 of 32 webcasts
Key facts CIK 1581280 CUSIP 90184D100 13F (30d) 73 filings 68 filers Visit website Investor relations